This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Nicole Ball: Innovator in Pharmaceutical Formulations
Introduction
Nicole Ball is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of arthritis and psoriasis. With a total of 4 patents to her name, her work has the potential to impact many lives.
Latest Patents
Nicole's latest patents focus on innovative methods of treatment using etanercept. One of her notable inventions is titled "Methods of treatment of arthritis and/or psoriasis with pharmaceutical formulations of etanercept." This invention relates to the formulation of pharmaceutical compositions of etanercept and includes methods for removing buffer and formulating these compositions. Another patent, "Pharmaceutical formulations and methods of making the same," further explores the formulation of etanercept, emphasizing the importance of effective pharmaceutical compositions.
Career Highlights
Nicole Ball is currently associated with Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to collaborate with other talented professionals in the field, enhancing her contributions to pharmaceutical innovations.
Collaborations
One of her notable coworkers is Monica Michelle Goss, who also plays a significant role in the development of pharmaceutical formulations. Their collaboration exemplifies the teamwork necessary for advancing medical treatments.
Conclusion
Nicole Ball's innovative work in pharmaceutical formulations demonstrates her commitment to improving treatment options for patients with arthritis and psoriasis. Her contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
